Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, multicenter study. Australian IL-2 Study Group (Q45752982)
Jump to navigation
Jump to search
scientific article published in October 1998
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, multicenter study. Australian IL-2 Study Group |
scientific article published in October 1998 |
Statements
1 reference
Outpatient continuous intravenous interleukin-2 or subcutaneous, polyethylene glycol-modified interleukin-2 in human immunodeficiency virus-infected patients: a randomized, controlled, multicenter study. Australian IL-2 Study Group (English)
1 reference
Carr A
1 reference
Emery S
1 reference
Lloyd A
1 reference
Hoy J
1 reference
Garsia R
1 reference
French M
1 reference
Stewart G
1 reference
Fyfe G
1 reference
Cooper DA
1 reference
1 October 1998
1 reference
178
1 reference
4
1 reference
992-999
1 reference
Identifiers
1 reference
1 reference